Rockefeller Capital Management
PAHC icon

Rockefeller Capital Management’s Phibro Animal Health PAHC Stock Holding History

Rockefeller Capital Management’s Portfolio PAHC Stock Details PAHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$12.4K Sell
396
-8
-2% -$338 ﹤0.01% 3921
2026
Q1 		$22.3K Buy
404
+296
+274% +$14.1K ﹤0.01% 3671
2025
Q4 		$4.04K Sell
108
-4
-4% -$162 ﹤0.01% 4138
2025
Q3 		$4.53K Buy
+112
New +$3.7K ﹤0.01% 3896
2023
Q1 		– Sell
-2,494
Closed -$32K – 3314
2022
Q4 		$32K Buy
2,494
+2,484
+24,840% +$33.3K ﹤0.01% 2600
2022
Q3 		$0 Sell
10
-386
-97% -$6.67K ﹤0.01% 4252
2022
Q2 		$7K Buy
396
+380
+2,375% +$7.2K ﹤0.01% 3315
2022
Q1 		$0 Hold
16
– – ﹤0.01% 4020
2021
Q4 		$0 Hold
16
– – ﹤0.01% 3936
2021
Q3 		$0 Buy
+16
New +$385 ﹤0.01% 3803
2020
Q3 		– Sell
-26
Closed -$1K – 2733
2020
Q2 		$1K Buy
+26
New +$646 ﹤0.01% 2482

Other funds holding PAHC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $34.9B AUM 72.7% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Rockefeller Capital Management's PAHC Position: Q2 2026 in Review

Rockefeller Capital Management reduced its Phibro Animal Health (PAHC) stake by 2% in Q2 2026, selling an estimated $338 and leaving 396 shares worth $12.4K. The position accounts for ﹤0.01% of the portfolio, ranked #3921.

Rockefeller Capital Management first reported a position in PAHC in Q2 2020 and has held it in 11 quarters since. The position peaked at $32K in Q4 2022. 208 funds tracked by Wall St. Rank hold PAHC as of Q2 2026.

  • Rockefeller Capital Management held 396 shares of Phibro Animal Health worth $12.4K as of Q2 2026.
  • Rockefeller Capital Management sold 8 Phibro Animal Health shares in Q2 2026, an estimated $338.
  • Phibro Animal Health made up ﹤0.01% of Rockefeller Capital Management's portfolio in Q2 2026, its #3921 holding.
  • Rockefeller Capital Management first reported a position in Phibro Animal Health in Q2 2020 and has held it in 11 quarters since.
  • Rockefeller Capital Management's Phibro Animal Health position peaked at $32K in Q4 2022.
  • 208 funds tracked by Wall St. Rank held Phibro Animal Health as of Q2 2026.

Based on Rockefeller Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.